Treatment of colds, flu like infections and other general nasal based infections with a solution containing iodine and other broad spectrum microbicides and a method for its use

The invention relates generally to a process which utilizes iodine as a wide spectrum microbicide wherein the active agent may be implemented in nasal passages in the way of a decongestant type nose spray. The spray is intended particularly for human use. It’s to be implemented in case of known or suspected exposure of the individual to common cold virus, flu, or other infective parasitic brokers including for instance, bacteria, viruses, rickettsia, and even mould and fungus. The active agent is based on an iodine solution and might also include one or more of these: sodium hypochlorite solution, or a solution of chlorine or hypochlorites along with a salt of chloride, bromide or iodide. Alternatively, the solution may further contain iodine and a bromine solution, or a solution of potassium, bromine along with a salt of chloride, bromide or iodide like sodium chloride, zinc chloride, sodium bromide, zinc bromide, sodium iodide or zinc iodide. The potassium, chlorine, hypochlorites, bromine, chloride, bromide, and iodide may originally come from inorganic substances or organic compounds, that are then dissolved in the water. What’s more, the solution may include glycerin or another moisturizing or wetting agent for your nasal mucosa since the halogens or halides might be dehydrating or drying. Zinc gluconate or a zinc halide like zinc chloride, zinc bromide or zinc iodide might also be included to further render the nasal mucosa more slick and thus leave it more difficult for invading microbes to colonize the area.


To view all patent detail click here





Cold viruses or other microbes are occasionally transmitted by aerosol like by a water droplet that’s dispersed by coughing or sneezing, or from contact including, as an example, hand to hand touch by which a handshake transfers the microbesfrom one individual to the other and then the contaminated hands is drawn to the neighborhood of somebody’s nose. (As when touching the nose or scratching it or rubbing it.) It is generally considered that infective agents will multiply and grow in regionswhere they have the suitable temperature, nutrients, and other conditions conducive to growth or multiplication like in the nasal mucosa. Therefore, an object of the present invention is to employ a broad-spectrum microbicide like iodine to the region whereinfective viruses could be transmitted or transmitted, and would ordinarily multiply

A number of explanations could be proposed for the potency of the microbicide in cutting the risk of full-blown infection. By way of example, the essay may act to kill the microbe, or to render it ineffective. What’s more, the microbicidemay act to slow diffusion into a cell by tagging it with a heavy ion. This slowing of diffusion may impede the microbe’s multiplication and permit the body’s natural defenses to catch up and remove the microbes. What’s more, the nasal remedy can dilutethe attacking organism and scrub it out away from the optimal place for growth so as to weaken the statistical likelihood of success of the infection.

It is thus an object of the invention to employ a health representative to the region of entry of the infection, namely the nose, and especially the interior of the nose, the nasal fossae and the sinus regions inside the nose. This therapy could be remedialso as to inhibit an existing infection, or prophylactic in order to reduce spread to the lymph system by affecting the microbe in the nose. Thus, in accordance with a way of using the nasal spray, then it might be implemented as soon as the person hasdetermined that he or she has”caught” a cold. It might also be implemented after the person first starts to feel the initial indicators of grabbing a cold, such as stuffiness or muscular aches or fever. Or it might be applied prophylactically as soon as aperson has been subjected to others who have colds and has actual reason to be concerned about catching a cold after such an exposure. Moreover, it might be implemented in a similar way for cases of influenza and other infections for minimizing symptoms andextent of”infection”.


U.S. Pat.

No. 5,897,872 refers to an iodine containing solution for treatment or prevention of sinusitis and nasal congestion. The solution to be administered into the uterus and the nasal mucosa. Picciano admits that sinusitisis a condition that might have been triggered as an outcome of having had a cold or the flu. And he states that the improper drainage triggers sinusitis, after which remarks that a bacterial infection develops. In U.S. Pat. No. 5,897,872 that the iodinesolution is for treating sinusitis and or related conditions associated with or due to nasal congestion.

The present invention admits something new, namely an iodine based alternative may be of significant utility in the actual treatment of colds, flu, and other microbial infections that are localized or start out localized in the nasalarea. This is due to the exceptionally diverse and broad-spectrum anti inflammatory action of iodine, iodides, and other halogens and halides. Iodine, chlorine, bromine, iodides, bromides and chlorides may have anti-microbial action againstbacteria, viruses, and a host of other organisms. In the case of colds, influenza, and other similar infections, the cold or other infection triggers the congestion, not the other way round. The microbes readily penetrate deep into the un-congested nasalcavity of a healthy individual, start the infection and then cause the congestion, as the body seeks to fight them. The iodine, chlorine, hypochlorite, and bromine, iodides, bromides and chlorides will be effective at combating the actual microbialorganisms responsible for colds, flu and other illnesses.

IP reviewed by Plant-Grow agriculture technology news